CD61 (Megakaryocytic Cell Marker)

image not found

NABL Cap Accredited 
The Orange Healthcare CD61 (Megakaryocytic Cell Marker) Test is a specialised diagnostic investigation used to detect CD61, also known as integrin beta-3 (glycoprotein IIIa), a cell-surface protein expressed on platelets and megakaryocytes. CD61 forms part of the platelet glycoprotein IIb/IIIa complex, which plays an essential role in platelet aggregation and normal blood clotting. The Orange Healthcare CD61 (Megakaryocytic Cell Marker) Test helps identify megakaryocytic cell populations and supports the diagnosis and classification of acute megakaryoblastic leukaemia and certain platelet disorders. Abnormal CD61 expression may provide information about platelet function or megakaryocytic differentiation. Results should be interpreted alongside other immunophenotypic markers, blood counts, bone marrow findings, and clinical investigations.

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 3,750.00 Rs. 4,875.00

23% OFF

Sample Type: Blood

Fasting Not Required


Booking Procedure:
  1. Select your preferred Orange Health test or package on BookMyTest and complete your booking with your details.
  2. Pick a convenient time slot. A trained eMedic will be assigned and can reach you within 60 minutes of booking or at your scheduled time.
  3. At your selected time, a trained eMedic will visit your doorstep for safe and hygienic sample collection using a painless single-prick method. Samples are securely stored and transported to certified labs for processing.
  4. Doctor-verified reports are shared via WhatsApp, email, and the Orange Health app. You can also access them anytime from your registered account.

Frequently Asked Questions (FAQ's):

1. What is the Orange Healthcare CD61 (Megakaryocytic Cell Marker) Test?
It is a specialised laboratory test used to detect CD61 protein expression on platelets and megakaryocytes, helping identify megakaryocytic cell populations and investigate certain blood disorders.

2. Why is the CD61 (Megakaryocytic Cell Marker) Test performed?
The test is performed to support the diagnosis and classification of acute megakaryoblastic leukaemia, identify megakaryocytic differentiation in abnormal cells, and assist in evaluating selected platelet disorders.

3. What does a positive CD61 result indicate?
A positive result indicates CD61 expression in the examined cells. This may support megakaryocytic differentiation when interpreted alongside other markers, such as CD41 and CD42. CD61 positivity alone does not confirm malignancy.

4. What does a negative CD61 result indicate?
A negative result indicates that CD61 expression was not detected in the examined cell population. Reduced or absent expression may occur in certain platelet disorders, including Glanzmann thrombasthenia, or in some abnormal cell populations. Further investigations may be necessary.

5. Is fasting required for the Orange Healthcare CD61 (Megakaryocytic Cell Marker) Test?
Fasting is generally not required. However, patients undergoing bone marrow aspiration, tissue biopsy, or procedures involving sedation should follow the preparation instructions provided by their healthcare team.

6. What sample is required for the CD61 (Megakaryocytic Cell Marker) Test?
The required specimen depends on the clinical indication and testing method. Peripheral blood or bone marrow aspirate samples may be analysed using flow cytometry, while bone marrow or tissue biopsy specimens may be examined using immunohistochemistry to assess CD61 expression.

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab